GlassScriptPhysician profile
Benjamin Charles Carr
NPI 1154171742
$622.70
in general payments reported to CMS, 2019-2025
9 companies · $570 in 2025
The $570 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $52.68 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $186.15 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Enterra Medical, INC. | $125.55 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $111.46 | 2025 | |
| Tela Bio, INC. | $64.18 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Teleflex LLC | $35.56 | 2024-2025 | Quikclot, Quikclot |
| Access Pro Medical, LLC | $33.13 | 2025 | Matriderm |
| Avita Medical Americas, LLC | $31.30 | 2025 | Cohealyx, Recell, Permeaderm |
| Haemonetics Corporation | $18.51 | 2024 | Teg5000 Hemostasis Analyzer |
| Aroa Biosurgery Incorporated | $16.86 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.